Results 121 to 130 of about 23,985 (238)

Systemic anti‐cancer therapy associated with the occurrence of peripheral neurotoxicity and, specifically, peripheral neuropathy

International Journal of Cancer, Volume 159, Issue 2, Page 460-466, 15 July 2026.
What's new? While the effectiveness of systemic anticancer therapy is well documented, it commonly causes severe toxicity. This study of the 467 systemic anticancer therapy agents currently approved globally for clinical and/or research purposes found that peripheral neurotoxicity is associated with 45% of classical chemotherapies, 21% of targeted ...
Cassie Higgins, Lynn R. Gauthier, Blair H. Smith, Lesley Colvin   +3 more
wiley   +1 more source

Living Microbial Drugs

Chemistry – A European Journal, Volume 32, Issue 26, 11 July 2026.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik, Nazlıcan Tunç, Senem Şen, Urartu Özgür Şafak Şeker   +3 more
wiley   +1 more source

Model Dinamika Sel Tumor Dengan Terapi Pengobatan Menggunakan Virus Oncolytic [PDF]

, 2011
Selama ini virus diasosiasikan sebagai penyebab utama terjadinya berbagai penyakit. Namun, studi terbaru menunjukkan setidaknya ada beberapa virus yang memiliki kemampuan anti kanker yang dapat digunakan untuk terapi kanker metastatis.
Ali, Kusnanto, Endar H., Nugrahani, Hikmah, Rahmah   +2 more
core  

Emerging role of Natural killer cells in oncolytic virotherapy [PDF]

, 2015
Rauf Bhat, Jean Rommelaere Division of Tumor Virology, German Cancer Research Center, Heidelberg, Germany Abstract: Natural killer (NK) cells constitute a subtype of lymphocytes that initiate innate immune responses against tumors and virus-infected ...
Bhat R, Rommelaere J
core  

Oncolytic viro-chemotherapy exhibits antitumor effect in laryngeal squamous cell carcinoma cells and mouse xenografts [PDF]

, 2019
Yigang Wang,1 Binrong Wang,1 Junnan Liang,2 Caixia Cui,3 Chang Ying,1 Fang Huang,4 Buyun Ma,1 Xiumei Zhou,1 Liang Chu21College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou 310018, People’s Republic of China; 2Hepatic Surgery Center ...
Huang F, Ma B, Wang B, Ying C, Liang J, Wang Y, Cui C, Zhou X, Chu L   +8 more
core  

Advances in Oncolytic Viral Therapy in Melanoma: A Comprehensive Review

Vaccines
Checkpoint inhibitor therapy revolutionized the treatment of patients with melanoma. However, in patients where melanoma exhibits resistance to checkpoint inhibitor therapy, the treatment options are limited.
Ayushi Garg, Rohit Rao, Felicia Tejawinata, Gazi Amena Noor Shamita, McKay S. Herpel, Akihiro Yoshida, Gordon Goolamier, Jessica Sidiropoulos, Iris Y. Sheng, Salim-Tamuz Abboud, Luke D. Rothermel, Nami Azar, Ankit Mangla   +12 more
doaj   +1 more source

Enhancing the therapeutic potential of oncolytic virotherapy for melanoma treatment [PDF]

reservedMelanoma remains a globally relevant malignancy. Although various treatments have been developed over time, few are effective against rarer mutations.
PAROLIN, BEATRICE
core  

Model Matematika Terapi Tumor dengan Virus Oncolytic [PDF]

, 2009
Pada skripsi ini dibahas konstruksi dan analisis model matematika terapi tumor dengan virus oncolytic. Pada konstruksi model digunakan analisis kompartemen.
HarisAsriCandraDewi
core  

Determining new functions of Adenovirus VA-RNAI and its use in cancer therapy [PDF]

, 2009
PhDVirus-Associated RNA I (VA-RNAI; VAI) of adenovirus is a nontranslated RNA molecule known to interact with several dsRNA-binding molecules in host cells.
Binny, Christopher Jonathan
core  

Analisis Model Terapi Tumor Dengan Virus Oncolytic [PDF]

, 2013
Padaskripsiinidibahaskonstruksidananalisismodel matematikaterapi tumor dengan virus oncolytic. Diasumsikanbahwasel tumor dalamtubuhpenderitaterdiridarisel tumor yang tidakterinfeksi virus oncolyticx(t) dan yang terinfeksi virus oncolyticy(t ...
Roisa, Annisaa
core